Benzofuran derivatives are of great interest in medicinal chemistry and have drawn considerable attention due to their diverse pharmacological profiles including anticancer activity. Similarly, chalcones, which are common substructures of numerous natural products belonging to the flavonoid class, feature strong anticancer properties. A novel series of chalcones, 3-aryl-1-(5-bromo-1-benzofuran-2-yl)-2-propanones propenones (3a–f), were designed, synthesized, and characterized.In vitroantitumor activities of the newly synthesized (3a–f) and previously synthesized (3g–j) chalcone compounds were determined by using human breast (MCF-7) and prostate (PC-3) cancer cell lines. Antitumor properties of all compounds were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell viability assay for the tested chalcone compounds was performed and thelogIC50values of the compounds were calculated after 24-hour treatment. Our results indicate that the tested chalcone compounds show antitumor activity against MCF-7 and PC-3 cell lines (p<0.05).
苯并呋喃衍生物在药物化学中备受关注,由于其多样的药理特性,包括抗癌活性,已引起广泛关注。同样,香豆素类天然产物中常见的亚结构——川芎素,具有强大的抗癌性能。设计、合成和表征了一系列新型的川芎素,3-芳基-1-(5-溴-1-苯并呋喃-2-基)-2-丙酮丙酮(3a-f)。通过使用人类乳腺癌(MCF-7)和前列腺癌(PC-3)细胞株,确定了新合成的(3a-f)和先前合成的(3g-j)川芎素化合物的体外抗肿瘤活性。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物(MTT)试验确定了所有化合物的抗肿瘤特性。对测试的川芎素化合物进行细胞存活率试验,并在处理24小时后计算了这些化合物的IC50值。我们的结果表明,测试的川芎素化合物对MCF-7和PC-3细胞株显示出抗肿瘤活性(p < 0.05)。